St. Louis, MO, United States of America

Nigel J Cairns



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Nigel J. Cairns

Introduction

Nigel J. Cairns, based in St. Louis, MO, is a prominent inventor with a focus on advancements in the medical field. With a total of three patents to his name, his work is particularly noteworthy in relation to neurodegenerative diseases, specifically TDP-43 proteinopathies.

Latest Patents

Cairns' latest patented invention revolves around sequences associated with TDP-43 proteinopathies and their applications. This groundbreaking invention provides nucleic acids and peptides that serve as valuable tools for identifying subjects at risk for TDP-43 proteinopathy. Additionally, the invention includes an array comprising the nucleic acids and peptides, further enhancing its utility in medical diagnostics and research.

Career Highlights

Nigel J. Cairns is affiliated with Washington University, a prestigious institution that helps catalyze his research and innovative efforts. His commitment to advancing medical science is reflected in his patents and continuous contributions to understanding complex neurological disorders.

Collaborations

Throughout his career, Cairns has collaborated with esteemed colleagues such as Robert H. Baloh and Alan Pestronk. These partnerships foster a collaborative environment that enhances the quality and impact of their research endeavors.

Conclusion

Nigel J. Cairns represents a dedicated and innovative spirit in the arena of medical research and inventions. His patents not only illustrate his knowledge and expertise but also offer promising solutions for the identification and understanding of TDP-43 proteinopathies. As he continues his work at Washington University, his contributions will undoubtedly make a lasting impact on the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…